contribs[] |
{'index': 0, 'creator_id': None, 'creator': None, 'raw_name': 'Manjit Kaur Rana', 'given_name': None, 'surname': None, 'role': 'author', 'raw_affiliation': None, 'extra': None}
{'index': 1, 'creator_id': None, 'creator': None, 'raw_name': 'M Mahajan', 'given_name': None, 'surname': None, 'role': 'author', 'raw_affiliation': None, 'extra': None}
{'index': 2, 'creator_id': None, 'creator': None, 'raw_name': 'Deepak Arora', 'given_name': None, 'surname': None, 'role': 'author', 'raw_affiliation': None, 'extra': None}
{'index': 3, 'creator_id': None, 'creator': None, 'raw_name': 'Parvinder Sandhu', 'given_name': None, 'surname': None, 'role': 'author', 'raw_affiliation': None, 'extra': None}
{'index': 4, 'creator_id': None, 'creator': None, 'raw_name': 'Rakesh Sethi', 'given_name': None, 'surname': None, 'role': 'author', 'raw_affiliation': None, 'extra': None}
{'index': 5, 'creator_id': None, 'creator': None, 'raw_name': 'Assistant Professor', 'given_name': None, 'surname': None, 'role': 'author', 'raw_affiliation': None, 'extra': None}
|
refs[] |
{'index': 0, 'target_release_id': None, 'extra': {'authors': ['G Bodey', 'M Buckley', 'Y Sathe', 'E Freireich'], 'volume': '64'}, 'key': 'b0', 'year': 1966, 'container_name': None, 'title': 'Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia', 'locator': None}
{'index': 1, 'target_release_id': None, 'extra': {'authors': ['S Blackwell', 'J Crawford']}, 'key': 'b1', 'year': 1994, 'container_name': None, 'title': 'Filgrastim (r-metHuG-CSF) in the chemotherapy setting', 'locator': None}
{'index': 2, 'target_release_id': None, 'extra': {'authors': ['J Talcott', 'R Siegel', 'R Finberg', 'L Goldman'], 'volume': '10'}, 'key': 'b2', 'year': 1992, 'container_name': None, 'title': 'Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule', 'locator': None}
{'index': 3, 'target_release_id': None, 'extra': {'authors': ['W Hughes', 'D Armstrong', 'G Bodey', 'E Bow', 'A Brown', 'Calandra'], 'volume': '34'}, 'key': 'b3', 'year': 2002, 'container_name': None, 'title': 'guidelines for the use of antimicrobial agents in neutropenic patients with cancer', 'locator': None}
{'index': 4, 'target_release_id': None, 'extra': {'authors': ['G Lyman', 'N Kuderer', 'O Agboola', 'L Balducci'], 'volume': '10'}, 'key': 'b4', 'year': 2003, 'container_name': None, 'title': 'Evidence-based use of colony-stimulating factors in elderly cancer patients', 'locator': None}
{'index': 5, 'target_release_id': None, 'extra': {'authors': ['V Caggiano', 'R Weiss', 'T Rickert'], 'volume': '103'}, 'key': 'b5', 'year': 2005, 'container_name': None, 'title': 'Linde-Zwirble WT. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy', 'locator': None}
{'index': 6, 'target_release_id': None, 'extra': {'authors': ['S Lewis']}, 'key': 'b6', 'year': 2006, 'container_name': None, 'title': 'Reference ranges and normal values', 'locator': None}
{'index': 7, 'target_release_id': None, 'extra': {'authors': ['T Smith', 'J Khatcheressian', 'G Lyman', 'H Ozer', 'J Armitage', 'L Balducci'], 'volume': '24'}, 'key': 'b7', 'year': 2006, 'container_name': None, 'title': 'update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline', 'locator': None}
{'index': 8, 'target_release_id': None, 'extra': {'authors': ['J Crawford', 'D Dale', 'G Lyman'], 'volume': '100'}, 'key': 'b8', 'year': 2004, 'container_name': None, 'title': 'Chemotherapyinduced neutropenia: risks, consequences, and new directions for its management', 'locator': None}
{'index': 9, 'target_release_id': None, 'extra': {'authors': ['S Schimpff', 'H Gaya', 'J Klastersky', 'M Tattersall', 'S Zinner'], 'volume': '137'}, 'key': 'b9', 'year': 1978, 'container_name': None, 'title': 'Three antibiotic regimens in the treatment of infec-tion in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group', 'locator': None}
{'index': 10, 'target_release_id': None, 'extra': {'authors': ['J Chang'], 'issue': None, 'volume': '36'}, 'key': 'b10', 'year': 2000, 'container_name': None, 'title': 'Chemotherapy dose reduction and delay in clinical practice, evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer', 'locator': None}
{'index': 11, 'target_release_id': None, 'extra': {'authors': ['G Lyman', 'N Kuderer', 'J Greene', 'L Balducci'], 'issue': '12', 'volume': '34'}, 'key': 'b11', 'year': 1998, 'container_name': None, 'title': 'The economics of febrile neutropenia: implications for the use of 8 Advances in Bioinformatics golony-stimulating factors', 'locator': None}
{'index': 12, 'target_release_id': None, 'extra': {'authors': ['J Silber', 'M Fridman', 'R Dipaola', 'M Erder', 'M Pauly', 'K Fox'], 'issue': None, 'volume': '16'}, 'key': 'b12', 'year': 1998, 'container_name': None, 'title': 'First-cyclebloodcountsandsubsequent neutropenia, dose reduction, or delay in early-stage breast cancertherapy', 'locator': None}
{'index': 13, 'target_release_id': None, 'extra': {'authors': ['C Uyl-De Groot', 'E Vellenga', 'Ffh Rutten'], 'issue': None, 'volume': '32'}, 'key': 'b13', 'year': 1996, 'container_name': None, 'title': 'An economic Model to assess the savings from a clinical application of haematopoietic growth factors', 'locator': None}
{'index': 14, 'target_release_id': None, 'extra': {'authors': ['P Jenkins', 'S Freeman'], 'issue': None, 'volume': '20'}, 'key': 'b14', 'year': 2009, 'container_name': None, 'title': 'Pretreatment haematological laboratory values predict for excessive myelosuppression in patients receiving adjuvant FEC chemotherapy for breast cancer', 'locator': None}
{'index': 15, 'target_release_id': None, 'extra': {'authors': ['G Dranitsaris', 'D Rayson', 'M Vincent', 'J Chang', 'K Gelmon', 'D Sandor'], 'issue': None, 'volume': '31'}, 'key': 'b15', 'year': 2008, 'container_name': None, 'title': 'Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model', 'locator': None}
{'index': 16, 'target_release_id': None, 'extra': {'authors': ['E Rivera', 'Haim Erder', 'M Fridman', 'M Frye', 'D Hortobagyi', None], 'issue': None, 'volume': None}, 'key': 'b16', 'year': 2003, 'container_name': None, 'title': 'First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study', 'locator': None}
{'index': 17, 'target_release_id': None, 'extra': {'authors': ['J Matsubara', 'M Ono', 'A Negishi', 'H Ueno', 'T Okusaka', 'Furuse Jn'], 'issue': '13', 'volume': '27'}, 'key': 'b17', 'year': 2009, 'container_name': None, 'title': 'Identification of a predictive biomarker for hematologic toxicities of gemcitabine', 'locator': None}
{'index': 18, 'target_release_id': None, 'extra': {'authors': ['A Uys', 'B Rapoport', 'H Fickl', 'Pwa Meyer', 'R Anderson'], 'issue': None, 'volume': '16'}, 'key': 'b18', 'year': 2007, 'container_name': None, 'title': 'Prediction of outcome in cancer patients with febrile neutropenia: comparison of the multinational association of supportive care in cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β,-6,-8 and-10', 'locator': None}
{'index': 19, 'target_release_id': None, 'extra': {'authors': ['M Moreau', 'J Klastersky', 'A Schwarzbold', 'F Muanza', 'A Georgala', 'M Aoun'], 'issue': None, 'volume': '20'}, 'key': 'b19', 'year': 2009, 'container_name': None, 'title': 'A general chemotherapy myelotoxicity scoretopredictfebrileneutropenia in hematological malignancies', 'locator': None}
{'index': 20, 'target_release_id': None, 'extra': {'authors': ['Kvi Rolston'], 'issue': None, 'volume': '16'}, 'key': 'b20', 'year': 2000, 'container_name': None, 'title': 'Prediction of neutropenia', 'locator': None}
|